Trial: 201405031

An Open-Label, Phase 2 Basket Study of Neratinib in Patients with Solid Tumors with Somatic Activating HER Mutations

Phase

II

Principal Investigator

Park, Haeseong

Disease Site

Brain and Nervous System; Lung

Learn more about this study at: clinicaltrials.gov